The p53 tumor suppressor protein binds to both cellular and viral prot
eins, which influence its biological activity. One such protein is the
large E1b tumor antigen(1) (E1b58kDa) from adenoviruses (Ads), which
abrogates the ability of p53 to transactivate various promoters(2). Th
is inactivation of p53 function is believed to be the mechanism by whi
ch E1b58kDa contributes to the cell transformation process(2). Althoug
h the p53-E1b58kDa complex occurs during infection(3) and is conserved
among different serotypes(4), there are limited data demonstrating th
at it has a role in virus replication. However, loss of p53 expression
occurs after adenovirus infection of human cells(4,5) and an E1b58kDa
deletion mutant (Onyx-015, also called dl 1520) selectively replicate
s in p53-defective cells(6,7). These (and other) data indicate a plaus
ible hypothesis is that loss of p53 function may be conducive to effic
ient adenovirus replication. However, wild-type (wt) Ad5 grows more ef
ficiently in cells expressing a wt p53 protein(5). These studies indic
ate that the hypothesis may be an oversimplification. Here, we show th
at cells expressing wt p53, as well as p53-defective cells, allow aden
ovirus replication, but only cells expressing wt p53 show evidence of
virus-induced cytopathic effect. This correlates with the ability of a
denovirus to induce cell death. Our data indicate that p53 plays a nec
essary part in mediating cellular destruction to allow a productive ad
enovirus infection. In contrast, p53-deficient cells are less sensitiv
e to the cytolytic effects of adenovirus and as such raise questions a
bout the use of E1b58kDa-deficient adenoviruses in tumor therapy(6,7).